Bmpr1a Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bmpr1a gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bmpr1a Rat Pre-designed siRNA Set A contains three designed siRNAs for Bmpr1a gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BMPR1B Human Pre-designed siRNA Set A contains three designed siRNAs for BMPR1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bmpr1b Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bmpr1b gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bmpr1b Rat Pre-designed siRNA Set A contains three designed siRNAs for Bmpr1b gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BMPR2 Human Pre-designed siRNA Set A contains three designed siRNAs for BMPR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bmpr2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bmpr2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bmpr2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Bmpr2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BMPR2-IN-1 (Compound 8a) is a BMPR2 inhibitor with an IC50 of 506 nM and a KD of 83.5 nM. BMPR2-IN-1 can be used for research of pulmonary arterial hypertension, Alzheimer’s disease and cancer[1].

BMPR2-IN-1 (Compound 8a) is a BMPR2 inhibitor with an IC50 of 506 nM and a KD of 83.5 nM. BMPR2-IN-1 can be used for research of pulmonary arterial hypertension, Alzheimer’s disease and cancer[1].

BMS-932481 is an orally active modulator for γ-secretase, selectively reduce Aβ1-42 and Aβ1-40 production, with IC50s of 6.6 and 25.3 nM, respectively[1].

BMS-960 is a potent and selective S1P1 receptor agonist containing isoxazole, which can be used in the research of immune diseases and vascular diseases[1].

BMS-960 free base is a potent and selective S1P1 receptor agonist containing isoxazole, which can be used in the research of immune diseases and vascular diseases[1].

BMS-986325 (anti-CD40) is a CD40 inhibitor, and can be used for primary Sjögren’s syndrome research[1].

BMS-986325 (anti-CD40) is a CD40 inhibitor, and can be used for primary Sjögren’s syndrome research[1].

BMS-986325 (anti-CD40) is a CD40 inhibitor, and can be used for primary Sjögren’s syndrome research[1].

BMS-986365 is a selective heterobifunctional ligand-directed degrader (LDD) targeting the androgen receptor (AR). BMS-986365 demonstrated significant in vivo potency, degrading AR, inhibiting AR signaling, and inhibiting tumor growth in animal models of advanced prostate cancer.

BMS-986365 is a selective heterobifunctional ligand-directed degrader (LDD) targeting the androgen receptor (AR). BMS-986365 demonstrated significant in vivo potency, degrading AR, inhibiting AR signaling, and inhibiting tumor growth in animal models of advanced prostate cancer.

BMS-986365 is a selective heterobifunctional ligand-directed degrader (LDD) targeting the androgen receptor (AR). BMS-986365 demonstrated significant in vivo potency, degrading AR, inhibiting AR signaling, and inhibiting tumor growth in animal models of advanced prostate cancer.

BMS-986365 is a selective heterobifunctional ligand-directed degrader (LDD) targeting the androgen receptor (AR). BMS-986365 demonstrated significant in vivo potency, degrading AR, inhibiting AR signaling, and inhibiting tumor growth in animal models of advanced prostate cancer.

BMS-986365 is a selective heterobifunctional ligand-directed degrader (LDD) targeting the androgen receptor (AR). BMS-986365 demonstrated significant in vivo potency, degrading AR, inhibiting AR signaling, and inhibiting tumor growth in animal models of advanced prostate cancer.

BMS1 Human Pre-designed siRNA Set A contains three designed siRNAs for BMS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BMT2 Human Pre-designed siRNA Set A contains three designed siRNAs for BMT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BMX Human Pre-designed siRNA Set A contains three designed siRNAs for BMX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bmx Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bmx gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Bmx Rat Pre-designed siRNA Set A contains three designed siRNAs for Bmx gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

BN-82685 is a a quinone-based CDC25 inhibitor with IC50 of 201 nM, 117 nM, 109 nM, 160 nM, 249 nM, for CDC25C, CDC25C-cat, CDC25A, CDC25B2, CDC25B3, respectively. BN-82685 plays an important role in cancer research[1].

BN-82685 is a a quinone-based CDC25 inhibitor with IC50 of 201 nM, 117 nM, 109 nM, 160 nM, 249 nM, for CDC25C, CDC25C-cat, CDC25A, CDC25B2, CDC25B3, respectively. BN-82685 plays an important role in cancer research[1].

BN-82685 is a a quinone-based CDC25 inhibitor with IC50 of 201 nM, 117 nM, 109 nM, 160 nM, 249 nM, for CDC25C, CDC25C-cat, CDC25A, CDC25B2, CDC25B3, respectively. BN-82685 plays an important role in cancer research[1].

BN-82685 is a a quinone-based CDC25 inhibitor with IC50 of 201 nM, 117 nM, 109 nM, 160 nM, 249 nM, for CDC25C, CDC25C-cat, CDC25A, CDC25B2, CDC25B3, respectively. BN-82685 plays an important role in cancer research[1].

BN-82685 is a a quinone-based CDC25 inhibitor with IC50 of 201 nM, 117 nM, 109 nM, 160 nM, 249 nM, for CDC25C, CDC25C-cat, CDC25A, CDC25B2, CDC25B3, respectively. BN-82685 plays an important role in cancer research[1].

BNC1 Human Pre-designed siRNA Set A contains three designed siRNAs for BNC1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BNC2 Human Pre-designed siRNA Set A contains three designed siRNAs for BNC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BNIP1 Human Pre-designed siRNA Set A contains three designed siRNAs for BNIP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BNIP2 Human Pre-designed siRNA Set A contains three designed siRNAs for BNIP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BNIP3 Human Pre-designed siRNA Set A contains three designed siRNAs for BNIP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BNIP3L Human Pre-designed siRNA Set A contains three designed siRNAs for BNIP3L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BNIPL Human Pre-designed siRNA Set A contains three designed siRNAs for BNIPL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

BNP (7-32), porcine (pBNP-26) is an atrial natriuretic peptide, which utilized in radioimmunoassay[1].

BNT411 is a selective TLR7 agonist that can induce the release of IFNa both in vivo and in vitro. BNT411 has anticancer activity and can be used in cancer research, including non-small cell lung cancer, pancreatic cancer, and untreated extensive-stage small cell lung cancer (ES-SCLC)[1].

BOC Human Pre-designed siRNA Set A contains three designed siRNAs for BOC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Boc-Asp(OBzl)-CMK is an inhibitor for IL-1 converting enzyme (ICE, caspase1). Boc-Asp(OBzl)-CMK prevents death of CHP100 neuroblastoma cell, and IL-1β release elicited by the viral coat protein[1].

Boc-Glu(OtBu)-OH is a glutamate derivative, with the protecting group of Boc- and OtBu[1].

Boc-Leu-Ser-Thr-Arg-AMC is a fluorogenic AMC-linked protease substrate[1].

Boc-NHCH2-Ph-Py-NH2 is the linker for PROTAC molecule XYD190 (HY-161494)[1].

Boc-NHCH2-Ph-pyrimidine-NH2 is the linker for PROTAC molecule XYD198 (HY-161498)[1].

Boc-Orn(Z)-OH (Nα-Boc-Nδ-Cbz-L-ornithine) is a biochemical reagent that can be used as a biological material or organic compound for life science related research[1].

BOD1 Human Pre-designed siRNA Set A contains three designed siRNAs for BOD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.